FDA's Makary Resigns With Agency in Turmoil

FDA Commissioner Marty Makary has resigned, and Kyle Diamantas will serve as acting commissioner, according to President Donald Trump. The change is a leadership update at a major health regulator rather than a policy announcement, so immediate market impact is likely limited. The news may matter for healthcare and biotech companies if it signals shifts in FDA oversight or approval posture.

Analysis

FDA Commissioner Marty Makary has resigned, and Kyle Diamantas will serve as acting commissioner, according to President Donald Trump. The change is a leadership update at a major health regulator rather than a policy announcement, so immediate market impact is likely limited. The news may matter for healthcare and biotech companies if it signals shifts in FDA oversight or approval posture.